Indivior Pharmaceuticals Inc
NASDAQ:INDV · NASDAQ Global Select
+$0.26 today
Vol 2.82M · Avg 2.08M
Filings
Ground the analysis in primary documents
Pair price history with recent company filings so you can connect market moves to the actual disclosures behind the business.
Price History
Dividend-adjusted closing price
Change
+174.55%
Period High
$40.61
Period Low
$13.69
Latest
$38.30
SEC Filings
Recent regulatory filings
No filings found.
Competitors
Peer companies in the same sector
Lantheus Holdings, Inc.
NASDAQ:LNTH
$6.75B
Praxis Precision Medicines, Inc.
NASDAQ:PRAX
$5.94B
Hinge Health, Inc.
NYSE:HNGE
$5.16B
Amneal Pharmaceuticals, Inc.
NASDAQ:AMRX
$5.13B
Crinetics Pharmaceuticals, Inc.
NASDAQ:CRNX
$3.76B
ACADIA Pharmaceuticals Inc.
NASDAQ:ACAD
$3.67B
Viking Therapeutics, Inc.
NASDAQ:VKTX
$3.58B
Option Care Health, Inc.
NASDAQ:OPCH
$3.47B
Supernus Pharmaceuticals, Inc.
NASDAQ:SUPN
$2.56B
ADMA Biologics, Inc.
NASDAQ:ADMA
$1.94B
What is the latest INDV filing?
The latest filing shown is 4 dated Jun 12, 2026.
How many recent filings does INDV have?
Intrinsic Alpha currently shows 20 recent filings for INDV.
Explore More
Continue the stock analysis
Jump to another research area for this company.